Animal models for autoimmune demyelinating disorders of the nervous system

Molecular Medicine

Volumn 6, Issue 2, 2000, Pages 88-91

  Gold, Ralf ^a,c   Hartung, Hans Peter ^b,c   Toyka, Klaus V ^c  

^a Department of Neurology   (Germany)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; AUTOIMMUNE DISEASE; DEMYELINATING DISEASE; EXPERIMENTAL MODEL; HUMAN; REVIEW;

ANIMALS; AUTOANTIGENS; DEMYELINATING AUTOIMMUNE DISEASES, CNS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNOTHERAPY; MICE; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; PRIMATES; RATS;

ANIMALIA;

EID: 0033978459     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1357-4310(99)01639-1     Document Type: Article

References (10)

1. Raine, C.S. et al. (1997) Multiple Sclerosis. Clinical and Pathological Basis. Chapman & Hall
2. Compston, A. et al. (1998) McAlpine's Multiple Sclerosis, (3rd edn), Churchill Livingstone
3. Antel, J. et al. eds (1998) Clinical Neuroimmunology. Blackwell Science
4. Gold, R. et al. (1997) T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci. 20, 399-404
5. Hafler, D.A. et al. (1996) TCR usage in human and experimental demyelinating disease. Immunol. Today 17, 152-159
6. Storch, M.K. et al. (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8, 681-694
7. Kojima, K. et al. (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J. Exp. Med. 180, 817-829
8. Lafaille, J.J. et al. (1994) High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice. Cell 78, 399-408
9. Hohlfeld, R. (1997) Biotechnological agents for the immunotherapy of multiple sclerosis - Principles, problems and perspectives. Brain 120, 865-916
10. Miller, D.J. et al. (1996) Central nervous system remyelination clinical application of basic neuroscience principles. Brain Pathol. 6, 331-344